Corcept Therapeutics · 1 week ago
Senior Manager/Associate Director, Commercial Analytics
Corcept Therapeutics is leading the way in the research and development of cortisol modulators. They are seeking a highly analytical and results-oriented Senior Manager or Associate Director, Commercial Analytics to join their Endocrinology division, where the role involves analyzing data to inform commercial strategy and drive insights across various analytics domains.
BiotechnologyMedicalPharmaceutical
Responsibilities
Analyze payer coverage data, formulary dynamics and access barriers to inform pricing and contracting strategies
Develop dashboards tracking payer mix, pull-through and patient affordability trends
Support Market Access and field access teams with insights that optimize payer engagement and reduce access barriers
Monitor and analyze patient access metrics (e.g., speed-to-therapy, adherence, abandonment, fulfillment)
Integrate specialty pharmacy, field and patient services data to provide a comprehensive view of the patient journey
Design and execute primary and secondary market research initiatives (PMR & SMR), collaborating with external research partners as needed
Collaborate with cross-functional teams (Sales, Marketing, Market Access, Medical) to drive integrated market insights supporting marketing campaigns and business strategies
Monitor competitor activities, landscape changes, therapeutic trends and industry developments
Translate findings into implications and recommendations for commercial leaders
Analyze claims, EMR, lab data to understand patient journey, treatment patterns, adherence and product value
Partner with Medical Affairs to support outcomes analyses, value communications and publications
Build integrated reporting across CRM, marketing, payer and third-party data (IQVIA, Symphony, Komodo)
Explore and apply advanced analytics techniques—including predictive modeling, machine learning and emerging AI/LLM approaches—to uncover new insights, improve forecasting and elevate commercial decision-making
Translate complex datasets into clear, decision-ready insights for senior leadership
Act as an internal consultant, providing data-driven recommendations to stakeholders across Sales, Marketing, Market Access, Medical, Finance and IT
Qualification
Required
Highly analytical and results-oriented
Ability to thrive in a fast-paced, collaborative environment
Adept at leading market research initiatives
Ability to interrogate syndicated data sources
Ability to communicate clear, data-driven narratives to senior leadership
Balance tactical analytical execution with strategic business impact
Work cross-functionally to translate complex insights into actionable recommendations
Collaborate with external data vendors and consultants while retaining ownership of the analysis, synthesis, and delivery of insights that drive commercial performance and strategy
Preferred
Hands-on expertise with pharma data (e.g., IQVIA, Symphony Health, Komodo Health), specialty pharmacy data, hub data, CRM data, and payer/coverage data (including MMIT's formulary, enrollment and policy datasets)
Hands-on expertise with both quantitative and qualitative market research
Hands-on experience with lab data and EMR is a strong plus
Strong technical skills in SQL and Excel
Experience with BI tools (e.g., Sigma, Tableau, Power BI) and CRM platforms (e.g., Veeva, Salesforce) preferred
Exceptional analytical and problem-solving skills, with the ability to synthesize information into actionable insights
Strong communicator with proven ability to present complex data to senior leadership and influence cross-functional partners
Proven ability to influence decision-making, manage competing priorities and drive alignment across cross-functional teams
6+ years of experience in consulting, commercial analytics, or payer analytics within pharma/biotech
Bachelor's degree required; advanced degree (MBA, MPH, MS, PhD, PharmD) preferred
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
Company data provided by crunchbase